Immunic | VTL - Sales Revenues

Stock Price
1.33
Daily Change
0.08 6.00%
Monthly
39.81%
Yearly
10.42%
Q1 Forecast
1.07

Immunic reported 0 in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
BioMarin Pharmaceutical USD 875M 99M Dec/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 67.33M 65.44M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Enanta Pharmaceuticals USD 16.96M 50.68M Dec/2024
Grifols EUR 2.34B 33.3M Mar/2026
Insmed USD 263.8M 121.8M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 724M 24M Dec/2025
Ultragenyx Pharmaceutical USD 207M 47M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
Xoma USD 25K 5M Sep/2024